55 research outputs found
Nursing home care for people with dementia and residents' quality of life, quality of care and staff well-being: Design of the Living Arrangements for people with Dementia (LAD) - study
<p>Abstract</p> <p>Background</p> <p>There is limited information available on how characteristics of the organization of nursing home care and especially group living home care and staff ratio contribute to care staff well being, quality of care and residents' quality of life. Furthermore, it is unknown what the consequences of the increasingly small scale organization of care are for the amount of care staff required in 2030 when there will be much more older people with dementia.</p> <p>Methods/Design</p> <p>This manuscript describes the design of the 'Living Arrangements for people with Dementia study' (LAD-study). The aim of this study is to include living arrangements from every part of this spectrum, ranging from large scale nursing homes to small group living homes. The LAD-study exists of quantitative and qualitative research. Primary outcomes of the quantitative study are wellbeing of care staff, quality of care and quality of life of residents. Furthermore, data concerning staff ratio and characteristics of the living arrangements such as group living home care characteristics are assessed. To get more in-depth insight into the barriers and facilitators in living arrangements for people with dementia to provide good care, focus groups and Dementia Care Mapping are carried out.</p> <p>Discussion</p> <p>Results of this study are important for policymakers, directors and staff of living arrangements providing nursing home care to people with dementia and essential for the development of methods to improve quality of care, residents' and staff well-being. Data collection will be repeated every two years, to generate knowledge on the results of changing policies in this field.</p
Inability to assess the safety of beta-, gamma- and delta- tocopherol and alpha-, beta-, gamma-, delta- and desmethyl-tocotrienol added for nutritional purposes as sources of beta-, gamma- and delta- tocopherol and alpha-, beta-, gamma-, delta- and desmethyl- tocotrienol in food supplements and the bioavailability of beta-, gamma-, delta- tocopherol and alpha-, beta-, gamma-, delta- and desmethyl-tocotrienol from the different sources, based on the supporting dossiers [1]
Calcium silicate and silicon dioxide/silicic acid gel added for nutritional purposes to food supplements
Inability to assess the safety of silicon-enriched yeast added for nutritional purposes as a source of silicon in food supplements and the bioavailability of silicon from this source, based on the supporting dossier [1]
Manganese ascorbate, manganese aspartate, manganese bisglycinate and manganese pidolate as sources of manganese added for nutritional purposes to food supplements
Chromium nitrate as a source of chromium added for nutritional purposes to food supplements
Inability to assess the safety of strontium-enriched yeast added for nutritional purposes as a source of strontium in food supplements and the bioavailability of strontium from this source, based on the supporting dossier [1]
Inability to assess the safety of molybdenum-enriched yeast added for nutritional purposes as a source of molybdenum in food supplements and the bioavailability of molybdenum from this source, based on the supporting dossier [1]
Inability to assess the safety of copper-enriched yeast added for nutritional purposes as a source of copper to food supplements, based on the supporting dossiers [1]
- …